Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation

Radiotherapy and Oncology

Volumn 109, Issue 2, 2013, Pages 297-302

  Antunes, Heliton S ^a   Herchenhorn, Daniel ^b   Small, Isabele A ^a   Araújo, Carlos M M ^b   Viégas, Celia Maria Pais ^b   Cabral, Elida ^b   Rampini, Mariana P ^a   Rodrigues, Pedro C ^b   Silva, Tereza G P ^b   Ferreira, Elza M S ^c   Dias, Fernando L ^b   Ferreira, Carlos G ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Therapy and Technology Development Section   (Brazil)

^c Radiation Oncology Division INCA ^*

Author keywords

Chemotherapy; Head and neck cancer; Low level laser therapy; Oral mucositis; Quality of life; Radiotherapy

Indexed keywords

CISPLATIN; PLACEBO;

ADULT; ARTICLE; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIODE LASER; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; EATING; EMOTION; FATIGUE; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDIUM PHOSPHIDE GALLIUM AND ALUMINUM DIODE LASER; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; ORAL MUCOSITIS; OVERALL SURVIVAL; PAIN; PATIENT SAFETY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SWALLOWING; TREATMENT OUTCOME;

CHEMOTHERAPY; HEAD AND NECK CANCER; LOW-LEVEL LASER THERAPY; ORAL MUCOSITIS; QUALITY OF LIFE; RADIOTHERAPY;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMATITIS;

EID: 84889569709     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.08.010     Document Type: Article

References (46)

1. E.B. Rubenstein, D.E. Peterson, and M. Schubert Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral gastrointestinal mucositis Cancer 100 2004 2026 2046
2. S.T. Sonis The pathobiology of mucositis Nat Rev Cancer 4 2004 277 284
3. S.T. Sonis Mucositis: the impact, biology and therapeutic opportunities of oral mucositis Oral Oncol 45 2009 1015 1020
4. A. Trotti, L.A. Bellm, and J.B. Epstein Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review Radiother Oncol 66 2003 253 262
5. M. Benasso, R. Corvò, and A. Ponzanelli Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck Ann Oncol 15 2004 646 652
6. M. Merlano, E.G. Russi, and G. Numico Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial Radiother Oncol 75 2005 193 196
7. G. Castro Jr, I.M.L. Snitcovsky, and E.M.M.S. Gebrim High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 264 2007 1475 1482
8. B.A. Murphy, J.L. Beaumont, and J. Isitt Mucositis-related and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy J Pain Symptom Manage 38 2009 522 532
9. C. Scully, J. Epstein, and S.T. Sonis Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis Head Neck 26 2004 77 84
10. G.M. McCarthy, and J.D. Awde Risk factors associated with mucositis in cancer patients receiving 5-fluouracil Oral Oncol 34 1998 484 490
11. D.B. McGuire, V. Altomonte, and D.E. Peterson Patterns of mucositis and pain in patients receiving chemotherapy and bone marrow transplantation Oncol Nurs Forum 20 1993 1493 1501
12. L.S. Elting, C.D. Cooksley, and M.S. Chambers Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies Int J Radiat Oncol Biol Phys 68 2007 1110 1120
13. N.J. Nonzee, N.A. Dandade, and T. Markossian Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis Cancer 113 2008 1446 1452
14. G. Russo, R. Haddad, and M. Posner Radiation treatment breaks and ulcerative mucositis in head and neck cancer Oncologist 13 2008 886 898
15. A. Barasch, D.E. Peterson, and J.M. Tanzer Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients Cancer 76 1995 2550 2556
16. D. Cowen, C. Tardieu, and M. Schubert Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplantation: results of a double blind randomized trial Int J Radiat Oncol Biol Phys 38 1997 697 703
17. H.S. Antunes, A.M. Azevedo, and L.F.S. Bouzas Low power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial Blood 109 2007 2250 2255
18. M.M. Schubert, F.P. Eduardo, and K.A. Guthrie A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation Supp Care Cancer 15 2007 1145 1154
19. G.B.L. Silva, E.F. Mendonça, and C. Bariani The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial Photomed Laser Sur 29 2011 27 31
20. R.J. Bensadoun, J.C. Franquin, and G. Ciais Low-energy He/Ne laser in the prevention of radiation-induced mucositis: a multicenter phase III randomized study in patients with head and neck cancer Supp Care Cancer 7 1999 244 252
21. G.A. Maiya, M.S. Sagar, and D. Fernandes Effect of low helium neon (He-Ne) laser therapy in the prevention and treatment of radiation-induced mucositis in head and neck cancer patients Ind J Med Res 124 2006 399 402
22. H. Arora, K.M. Pai, and G.A. Maiya Efficacy of He-Ne laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients Oral Surg Oral Med Oral Pathol Oral Radiol Oral Endod 105 2008 180 186
23. A. Gouveia de Lima, R.G. Villar, and G. Castro Jr. Oral mucositis prevention by low-level laser therapy in head and neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study Int J Radiat Oncol Biol Phys 82 2012 270 275
24. P.A. Carvalho, G.C. Jaguar, and A.C. Pellizzon Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients Oral Oncol 47 2011 1176 1181
25. A.P. Gautam, D.J. Fernandes, M.S. Vidyasagar, and A.G. Maiya Low level helium neon laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients - a randomized controlled trial Oral Oncol 48 2012 893 897 http://dx.doi.org/ 10.1016/j.oraloncology.2012.03.008
26. A.P. Gautam, D.J. Fernandes, M.S. Vidyasagar, A.G. Maiya, and B.M. Vadhiraja Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients. A triple blinded randomized controlled trial Radiother Oncol 104 2012 349 354 http://dx.doi.org/10.1016/j. radonc.2012. 06.011
27. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 1982 649 655
28. S.T. Sonis, P.D. Woods, and B.A. White Oral complications of cancer therapies. Pretreatment oral assessment NCI Monogr 9 1990 29 32
29. W.E. Wright Pretreatment oral health care interventions for radiation patients NCI Monogr 9 1990 57 59
30. P.B. Lockhart, and J. Clark Pretherapy dental status of patients with malignant conditions of the head and neck Oral Surg Oral Med Oral Pathol 77 1994 236 241
31. National Cancer Institute: oral complications of chemotherapy and head and neck radiations, 01/07 update. http://www.cancer.gov/cancertopics/pdq/ supportivecare /oralcomplications/healthprofessional.
32. ICRU Report 29 Dose specification for reporting external bean therapy with photons ans electrons 1978 International Commission on Radiation Units and Measurements Washington (DC)
33. ICRU Report 50 Prescribing, recording, and reporting photon bean therapy 1993 International Commission on Radiation Units and Measurements Bethesda (MD)
34. ICRU Report 62 Prescribing, recording, and reporting photon bean therapy supplement to ICRU Report 50) 1999 International Commission on Radiation Units and Measurements Bethesda (MD)
35. V. Ramirez-Amador, S. Silverman, and P. Mayer Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy Oral Sur Oral Med Oral Pathol 84 1997 149 153
36. S.W. Redding, R.C. Zellars, and W.R. Kirkpatrick Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer J Clin Microbiol 37 1999 3896 3900
37. O. Nicolatou-Galitis, A. Velegraki, and A. Sotiropoulou-Lontou Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy Supp Care Cancer 14 2006 44 45
38. WHO Handbook for reporting results of cancer treatment 1979 World Health Organization WHO Offset Publication No. 48, Geneva
39. S.T. Sonis, J.P. Eilers, and J.B. Epstein Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy Cancer 85 1999 2103 2113
40. National Cancer Institute National Cancer Institute common toxicity criteria, version 3.0 2003 National Cancer Institute Bethesda (MA)
41. WHO Cancer pain relief 2nd ed. 1996 World Health Organization Geneva
42. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
43. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
44. J.M. Bjordal, R.J. Bensadoun, and J. Tunèr A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis Supp Care Cancer 19 2011 1069 1077
45. M. Henke, M. Alfonsi, and P. Foa Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial J Clin Oncol 29 2011 2815 2820
46. Q.T. Le, H.E. Kim, and C.J. Schneider Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study J Clin Oncol 29 2011 2808 2814